KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Inventory (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Inventory data on record, last reported at $377.8 million in Q4 2025.

  • For Q4 2025, Inventory fell 1.08% year-over-year to $377.8 million; the TTM value through Dec 2025 reached $377.8 million, down 1.08%, while the annual FY2025 figure was $377.8 million, 1.08% down from the prior year.
  • Inventory reached $377.8 million in Q4 2025 per IDXX's latest filing, down from $391.6 million in the prior quarter.
  • Across five years, Inventory topped out at $396.0 million in Q1 2025 and bottomed at $225.6 million in Q1 2021.
  • Average Inventory over 5 years is $350.6 million, with a median of $380.1 million recorded in 2023.
  • Peak YoY movement for Inventory: soared 37.77% in 2022, then fell 3.84% in 2024.
  • A 5-year view of Inventory shows it stood at $269.0 million in 2021, then soared by 36.72% to $367.8 million in 2022, then increased by 3.39% to $380.3 million in 2023, then grew by 0.42% to $381.9 million in 2024, then dropped by 1.08% to $377.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $377.8 million in Q4 2025, $391.6 million in Q3 2025, and $392.6 million in Q2 2025.